Teva sees return to growth after opioid settlement, shares jump | Reuters
Allergan to own 10% stake in Teva
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs News | Al Jazeera
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva CEO Says He's Still Hoping For a Nationwide Opioid Settlement | Barron's
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva CEO Schultz likely won't renew employment contract: reports
New York could get $524M under opioid settlements with Teva - ABC News
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Pharmaceuticals USA found liable in opioids case - Newsday
Teva made smart decision to move to us: Allergan CEO
